| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |